Modular Medical, Inc. (NASDAQ:MODD – Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 189,700 shares, a decrease of 17.3% from the March 31st total of 229,500 shares. Currently, 0.7% of the company’s stock are sold short. Based on an average trading volume of 200,800 shares, the days-to-cover ratio is presently 0.9 days.
Insider Transactions at Modular Medical
In other news, Director Manchester Management Co Llc acquired 900,000 shares of Modular Medical stock in a transaction that occurred on Friday, February 16th. The stock was purchased at an average price of $1.10 per share, with a total value of $990,000.00. Following the completion of the transaction, the director now owns 3,118,227 shares in the company, valued at $3,430,049.70. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 32.34% of the stock is currently owned by company insiders.
Institutional Trading of Modular Medical
An institutional investor recently bought a new position in Modular Medical stock. Navigation Wealth Management Inc. bought a new stake in shares of Modular Medical, Inc. (NASDAQ:MODD – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 18,340 shares of the company’s stock, valued at approximately $34,000. Modular Medical accounts for approximately 13.8% of Navigation Wealth Management Inc.’s investment portfolio, making the stock its 2nd biggest holding. Navigation Wealth Management Inc. owned about 0.08% of Modular Medical at the end of the most recent quarter. 27.47% of the stock is currently owned by institutional investors.
Modular Medical Trading Up 2.5 %
Modular Medical (NASDAQ:MODD – Get Free Report) last issued its quarterly earnings data on Tuesday, February 13th. The company reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.06). On average, analysts forecast that Modular Medical will post -0.72 earnings per share for the current fiscal year.
Analyst Ratings Changes
Separately, Benchmark reiterated a “speculative buy” rating and issued a $5.00 target price on shares of Modular Medical in a research note on Thursday, March 21st.
Check Out Our Latest Stock Analysis on Modular Medical
About Modular Medical
Modular Medical, Inc operates as a development stage medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for diabetes. The company was founded in 1998 and is headquartered in San Diego, California.
Featured Stories
- Five stocks we like better than Modular Medical
- What is a Dividend King?
- The 3 Hottest Insiders Buys This Month
- The Significance of Brokerage Rankings in Stock Selection
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- Ride Out The Recession With These Dividend Kings
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.